share_log

HC Wainwright & Co. Maintains Buy on Unity Biotechnology, Lowers Price Target to $8

Moomoo 24/7 ·  Apr 16 07:05

HC Wainwright & Co. analyst Andrew Fein maintains Unity Biotechnology (NASDAQ:UBX) with a Buy and lowers the price target from $10 to $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment